Zachery Roger Reichert, MD, PhD, discusses key research questions to explore in early-stage prostate cancer.
Zachery Roger Reichert, MD, PhD
Advertisement
Articles by Zachery Roger Reichert, MD, PhD
Zachery Roger Reichert, MD, PhD, discusses the effects novel agents and pathways have had on the treatment of patients with prostate cancer.
Zachery Roger Reichert, MD, PhD, discusses novel agents and pathways under exploration in prostate cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
CD33-Directed CAR T-Cell Therapies Elicit Complete Remissions in Relapsed/Refractory AML
3
Subcutaneous Pembrolizumab Faces Scrutiny Over Convenience and Cost for Patients With Cancer
4
META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL
5